Huntington National Bank’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27K | Hold |
53
| – | – | ﹤0.01% | 2299 |
|
|
2025
Q1 | $1.32K | Hold |
53
| – | – | ﹤0.01% | 2321 |
|
|
2024
Q4 | $998 | Buy |
53
+31
| +141% | +$584 | ﹤0.01% | 2386 |
|
|
2024
Q3 | $331 | Sell |
22
-111
| -83% | -$1.67K | ﹤0.01% | 2562 |
|
|
2024
Q2 | $3.81K | Sell |
133
-47
| -26% | -$1.35K | ﹤0.01% | 1983 |
|
|
2024
Q1 | $5.26K | Buy |
180
+110
| +157% | +$3.21K | ﹤0.01% | 1901 |
|
|
2023
Q4 | $2.36K | Buy |
70
+55
| +367% | +$1.86K | ﹤0.01% | 2051 |
|
|
2023
Q3 | $460 | Sell |
15
-34
| -69% | -$1.04K | ﹤0.01% | 2274 |
|
|
2023
Q2 | $1.96K | Buy |
49
+33
| +206% | +$1.32K | ﹤0.01% | 2026 |
|
|
2023
Q1 | $653 | Buy |
16
+5
| +45% | +$204 | ﹤0.01% | 2069 |
|
|
2022
Q4 | $425 | Sell |
11
-1
| -8% | -$39 | ﹤0.01% | 1944 |
|
|
2022
Q3 | $0 | Buy |
12
+1
| +9% | – | ﹤0.01% | 2427 |
|
|
2022
Q2 | $0 | Hold |
11
| – | – | ﹤0.01% | 2427 |
|
|
2022
Q1 | $0 | Hold |
11
| – | – | ﹤0.01% | 2374 |
|
|
2021
Q4 | $0 | Hold |
11
| – | – | ﹤0.01% | 2312 |
|
|
2021
Q3 | $0 | Buy |
+11
| New | – | ﹤0.01% | 2060 |
|